EW Today - Aug 07: Upgraded Sales Outlook Boost

Impossibile aggiungere al carrello

Puoi avere soltanto 50 titoli nel carrello per il checkout.

Riprova più tardi

Rimozione dalla Lista desideri non riuscita.

Riprova più tardi

Non è stato possibile aggiungere il titolo alla Libreria

Per favore riprova

Non è stato possibile seguire il Podcast

Per favore riprova

Esecuzione del comando Non seguire più non riuscita

EW Today - Aug 07: Upgraded Sales Outlook Boost

Ascolta gratuitamente

Vedi i dettagli del titolo

Offerte di stagione | 0,99 €/mese per i primi 3 mesi

A seguire 9,99 €/mese – si applicano condizioni. Puoi disdire mensilmente.

A proposito di questo titolo

Hey there! It’s Joey, your go-to guy for stock talk. I’ve been in the investing game for a while, and today we’re looking at Edwards Lifesciences, ticker EW. It was a pretty chill day, just a slight uptick of about 0.4%. Not exactly fireworks, but hey, it’s green!

So, what’s the scoop? Edwards Lifesciences barely moved, but it seems like some folks are feeling a bit more optimistic. A couple of investment firms made some big moves recently. Orser Capital Management dropped over $2 million into EW, and Assenagon Asset Management snagged over half a million shares. Sounds like they see potential, right?

Now, let’s talk about why people are buzzing. The big news is that there’s been an upgrade in the sales outlook for their structural heart portfolio. Basically, analysts are saying that this could be a game changer for the company. When you hear “game changer,” it usually gets people excited. Plus, analysts are giving it a “Moderate Buy” rating, so you know, there’s some confidence there.

Looking ahead, Edwards is on the radar for its structural heart products, which might really shake things up if they hit those new sales targets.

Alright, that’s a wrap for today! Just remember, I’m here to share info and keep it fun, not to give financial advice. Catch you later!

Ancora nessuna recensione